Go,
Kudo's to you regards your post that Cardiogenics has adequate funding to conduct the Beta Site study. I discussed the costing of such a study today with a clinical pharmacologist who has experience in this area; without having access to the protocol approved by Wayne States's IRB, he ball parks the cost of this study at no more than $250,000, a sum within Cardiogenics' finances.
Ante